Literature DB >> 28648627

Myofilament protein dynamics modulate EAD formation in human hypertrophic cardiomyopathy.

Melanie A Zile1, Natalia A Trayanova2.   

Abstract

Patients with hypertrophic cardiomyopathy (HCM), a disease associated with sarcomeric protein mutations, often suffer from sudden cardiac death (SCD) resulting from arrhythmia. In order to advance SCD prevention strategies, our understanding of how sarcomeric mutations in HCM patients contribute to enhanced arrhythmogenesis needs to be improved. Early afterdepolarizations (EADs) are an important mechanism underlying arrhythmias associated with HCM-SCD. Although the ionic mechanisms underlying EADs have been studied in general, whether myofilament protein dynamics mechanisms also underlie EADs remains unknown. Thus, our goals were to investigate if myofilament protein dynamics mechanisms underlie EADs and to uncover how those mechanisms are affected by pacing rate, sarcomere length (SL), and different levels of HCM-induced myofilament remodeling. To achieve this, a mechanistically-based bidirectionally coupled human electrophysiology-force myocyte model under the conditions of HCM was constructed. HCM ionic remodeling included a reduced repolarization reserve, while HCM myofilament modeling involved altered thin filament activation. We found that the mechanoelectric feedback (MEF) on calcium dynamics in the bidirectionally coupled model, via Troponin C buffering of cytoplasmic Ca2+, was the myofilament mechanism underlying EADs. Incorporating MEF diminished the degree of repolarization reserve reduction necessary for EADs to emerge and increased the frequency of EAD occurrence, especially at faster pacing rates. Longer SLs and enhanced thin filament activation diminished the effects of MEF on EADs. Together these findings demonstrate that myofilament protein dynamics mechanisms play an important role in EAD formation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Computer modeling; Early afterdepolarizations; Hypertrophic cardiomyopathy; Mechanoelectric feedback

Mesh:

Substances:

Year:  2017        PMID: 28648627      PMCID: PMC5716843          DOI: 10.1016/j.pbiomolbio.2017.06.015

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  62 in total

1.  Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Christopher Semsarian
Journal:  Eur Heart J       Date:  2010-05-03       Impact factor: 29.983

2.  Approximate model of cooperative activation and crossbridge cycling in cardiac muscle using ordinary differential equations.

Authors:  John Jeremy Rice; Fei Wang; Donald M Bers; Pieter P de Tombe
Journal:  Biophys J       Date:  2008-01-30       Impact factor: 4.033

Review 3.  Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.

Authors:  Iacopo Olivotto; Giulia d'Amati; Cristina Basso; Albert Van Rossum; Monica Patten; Michele Emdin; Yigal Pinto; Benedetta Tomberli; Paolo G Camici; Michelle Michels
Journal:  Cardiovasc Res       Date:  2015-01-28       Impact factor: 10.787

4.  Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.

Authors:  Pieter A Vriesendorp; Arend F L Schinkel; Johan Van Cleemput; Rik Willems; Luc J L M Jordaens; Dominic A M J Theuns; Marjon A van Slegtenhorst; Thomy J de Ravel; Folkert J ten Cate; Michelle Michels
Journal:  Am Heart J       Date:  2013-07-16       Impact factor: 4.749

5.  Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Vlad C Vasile; Steve R Ommen; Melissa L Will; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

6.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

Review 7.  Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.

Authors:  Sabine Huke; Björn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2010-01-22       Impact factor: 5.000

8.  Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.

Authors:  Franz Baudenbacher; Tilmann Schober; Jose Renato Pinto; Veniamin Y Sidorov; Fredrick Hilliard; R John Solaro; James D Potter; Björn C Knollmann
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

9.  Syncope and risk of sudden death in hypertrophic cardiomyopathy.

Authors:  Paolo Spirito; Camillo Autore; Claudio Rapezzi; Paola Bernabò; Roberto Badagliacca; Martin S Maron; Sergio Bongioanni; Fabio Coccolo; N A Mark Estes; Caterina S Barillà; Elena Biagini; Giovanni Quarta; Maria Rosa Conte; Paolo Bruzzi; Barry J Maron
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

10.  A Comparative Study of Early Afterdepolarization-Mediated Fibrillation in Two Mathematical Models for Human Ventricular Cells.

Authors:  Soling Zimik; Nele Vandersickel; Alok Ranjan Nayak; Alexander V Panfilov; Rahul Pandit
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

View more
  6 in total

1.  Increased thin filament activation enhances alternans in human chronic atrial fibrillation.

Authors:  Melanie A Zile; Natalia A Trayanova
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

2.  Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.

Authors:  Chandra Prajapati; Marisa Ojala; Katriina Aalto-Setälä
Journal:  Dis Model Mech       Date:  2018-02-26       Impact factor: 5.758

Review 3.  Basic Research Approaches to Evaluate Cardiac Arrhythmia in Heart Failure and Beyond.

Authors:  Max J Cumberland; Leto L Riebel; Ashwin Roy; Christopher O'Shea; Andrew P Holmes; Chris Denning; Paulus Kirchhof; Blanca Rodriguez; Katja Gehmlich
Journal:  Front Physiol       Date:  2022-02-07       Impact factor: 4.566

4.  A mathematical model of hiPSC cardiomyocytes electromechanics.

Authors:  Mohamadamin Forouzandehmehr; Jussi T Koivumäki; Jari Hyttinen; Michelangelo Paci
Journal:  Physiol Rep       Date:  2021-11

Review 5.  Quantitative systems models illuminate arrhythmia mechanisms in heart failure: Role of the Na+ -Ca2+ -Ca2+ /calmodulin-dependent protein kinase II-reactive oxygen species feedback.

Authors:  Stefano Morotti; Eleonora Grandi
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-07-17

Review 6.  Mechano-electric and mechano-chemo-transduction in cardiomyocytes.

Authors:  Leighton T Izu; Peter Kohl; Penelope A Boyden; Masahito Miura; Tamas Banyasz; Nipavan Chiamvimonvat; Natalia Trayanova; Donald M Bers; Ye Chen-Izu
Journal:  J Physiol       Date:  2020-02-03       Impact factor: 6.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.